Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sandler

Showing results (671-680 of 870) with videos related to

Pageof 87
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapyJune L Chan, Susan W Lee, Benedick A Fraass, et al.
Transplantation|June 1, 1982
Use of digital subtraction angiography for the evaluation of living related renal transplant donorsS M Flechner, E N Rauschkolb, G Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2014
Adjuvant and salvage radiotherapy after prostatectomy: American Society of Clinical Oncology clinical practice guideline endorsementStephen J Freedland, R Bryan Rumble, Antonio Finelli, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 1992
Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy?W J Curran, S H Herbert, P M Stafford, et al.
European Urology|July 18, 2024
Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized TrialsDaniel E Spratt, Vinnie Y T Liu, Angela Y Jia, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 1992
A quantitative assessment of the addition of MRI to CT-based, 3-D treatment planning of brain tumorsR K Ten Haken, A F Thornton, H M Sandler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202Arnab Chakravarti, Michelle DeSilvio, Min Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|November 8, 2008
Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02Seth A Rosenthal, Kyoungwha Bae, Kenneth J Pienta, et al.
Plos One|April 2, 2025
Trafficking of the telomerase RNA using a novel genetic approachJessica K Day, Brett J Palmero, Amanda L Allred, et al.
Journal of the National Cancer Institute|July 10, 2014
Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trialsRonald C Chen, Peter Chang, Richard J Vetter, et al.
Pageof 87

Showing results (671-680 of 870) with videos related to

Sort By:
Pageof 87
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapyJune L Chan, Susan W Lee, Benedick A Fraass, et al.
Transplantation|June 1, 1982
Use of digital subtraction angiography for the evaluation of living related renal transplant donorsS M Flechner, E N Rauschkolb, G Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2014
Adjuvant and salvage radiotherapy after prostatectomy: American Society of Clinical Oncology clinical practice guideline endorsementStephen J Freedland, R Bryan Rumble, Antonio Finelli, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 1992
Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy?W J Curran, S H Herbert, P M Stafford, et al.
European Urology|July 18, 2024
Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized TrialsDaniel E Spratt, Vinnie Y T Liu, Angela Y Jia, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 1992
A quantitative assessment of the addition of MRI to CT-based, 3-D treatment planning of brain tumorsR K Ten Haken, A F Thornton, H M Sandler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202Arnab Chakravarti, Michelle DeSilvio, Min Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|November 8, 2008
Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02Seth A Rosenthal, Kyoungwha Bae, Kenneth J Pienta, et al.
Plos One|April 2, 2025
Trafficking of the telomerase RNA using a novel genetic approachJessica K Day, Brett J Palmero, Amanda L Allred, et al.
Journal of the National Cancer Institute|July 10, 2014
Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trialsRonald C Chen, Peter Chang, Richard J Vetter, et al.
Pageof 87